Literature DB >> 16778421

Could Jessner's lymphocytic infiltrate of the skin be a dermal variant of lupus erythematosus? An analysis of 210 cases.

Dan Lipsker1, Audrey Mitschler, Edouard Grosshans, Bernard Cribier.   

Abstract

BACKGROUND AND
OBJECTIVE: The objective of this study was to evaluate the relationship between Jessner's lymphocytic infiltration of the skin (JLI) and lupus erythematosus (LE), which has been the subject of debate since its initial description in 1953.
MATERIAL AND METHODS: This is a retrospective study including all patients with a histopathologically ascertained diagnosis of JLI performed at the Laboratoire d'Histopathologie Cutanée of the Strasbourg University Hospital between 1993 and 2003. Information about patient characteristics and follow-up data were retrieved between 2004 and 2005. Special attention was paid to features indicative of LE.
RESULTS: 210 consecutive patients (102 women and 108 men) with a mean age 42 years were diagnosed with JLI in the reference period. 175 patients (83%) had multiple lesions and 32 patients (15%) had only a single lesion at the time of diagnosis (data not available in 3 patients). The head, neck and upper part of the thorax were involved in 171 patients (81%). An annular or arciform configuration and/or arrangement were present in 111 patients (53%). Lesions consisted of red (100%) papules or plaques (98%). Mean follow-up was 4 years. Sixteen patients (7.6%) had proven LE. Only 2 patients (1%) developed >4 ACR criteria of systemic LE. Furthermore, 1 patient had antiphospholipid antibody syndrome and 2 patients had rheumatoid arthritis.
CONCLUSIONS: This high frequency of patients with typical features of LE strongly argues that JLI could be a dermal variant of LE and not an autonomous entity. It might be the cutaneous marker of a subset of LE patients with excellent prognosis.

Entities:  

Mesh:

Year:  2006        PMID: 16778421     DOI: 10.1159/000092832

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  6 in total

1.  Ustekinumab-induced drug eruption resembling lymphocytic infiltration (of Jessner-Kanof) and lupus erythematosus tumidus.

Authors:  Claudio Guarneri; Maria Lentini; Giovanni Polimeni; Roberta Giuffrida; Serafinella P Cannavò
Journal:  Br J Clin Pharmacol       Date:  2015-12-29       Impact factor: 4.335

2.  [Palpable arciforme migratory erythema].

Authors:  G Wagner; S Bartsch; C Rose; M M Sachse
Journal:  Hautarzt       Date:  2012-12       Impact factor: 0.751

3.  Jessner-Kanof disease induced by leflunomide: a dermal variant of cutaneous lupus?

Authors:  Laëtitia Sparsa; Naji Afif; Joëlle Goetz; Christelle Sordet; Emmanuel Chatelus; Dan Lipsker; Jean Sibilia
Journal:  Rheumatol Int       Date:  2009-10-13       Impact factor: 2.631

4.  Ki67 and CD31 Differential Expression in Cutaneous T-Cell Lymphoma and Its Mimickers: Association with Clinicopathological Criteria and Disease Advancement.

Authors:  Marwa Zohdy; Amal Abd El Hafez; Mona Younis Youssef Abd Allah; Hagar Bessar; Sherine Refat
Journal:  Clin Cosmet Investig Dermatol       Date:  2020-06-23

5.  Lupus erythematosus tumidus: clinical perspectives.

Authors:  Nikolaos Patsinakidis; Ocko Kautz; Bernhard F Gibbs; Ulrike Raap
Journal:  Clin Cosmet Investig Dermatol       Date:  2019-10-01

6.  Three Cases of Lymphocytic Infiltration of the Eyelid.

Authors:  Kyoko Sugioka; Akinobu Hayashi; Masako Ichishi; Yasuko Sugimoto; Koji Habe; Keiichi Yamanaka
Journal:  Dermatopathology (Basel)       Date:  2021-05-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.